BioCentury | Jun 2, 2020
Tools & Techniques
Spark’s approach to the problem of redosing AAV gene therapies
...2.0” ). In Nature Medicine Monday, scientists from Spark Therapeutics Inc., Genethon, INSERM and the Centre National de la Recherche Scientifique (CNRS)...
...efficacy. Sandi Wong, Assistant Editor Spark Therapeutics Inc. Roche Genethon Institut National de la Sante et de la Recherche Medicale (INSERM) Centre National de la Recherche Scientifique (CNRS) Gene...
...efficacy. Sandi Wong, Assistant Editor Spark Therapeutics Inc. Roche Genethon Institut National de la Sante et de la Recherche Medicale (INSERM) Centre National de la Recherche Scientifique (CNRS) Gene...